Get the latest news on Altamira Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CYTOF performance

Latest Altamira Therapeutics Stock News | OTC:CYTOF | Benzinga

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

ALTAMIRA THERAPEUTICS LTD by Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd

Press Releases

Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets

Comments

Altamira Therapeutics Stock News

News

Latest Altamira Therapeutics Stock News | OTC:CYTOF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga